Abstract
Conflicting results have been reported about activated leukocyte cell adhesion molecule (ALCAM) expression in breast cancer and its prognostic value. Little is known about the role of ALCAM levels in the serum of breast cancer patients. We analyzed soluble ALCAM (sALCAM) levels in the serum of 157 primary breast cancer patients and 48 healthy women by ELISA. In addition, we determined ALCAM protein expression by Western blot analysis (n = 120) and mRNA expression by cDNA microarray analysis (n = 115) in the tumor tissue of corresponding patients. sALCAM levels differed between patients and healthy controls (median 24.2 vs. 18.9 ng/ml, p < 0.001). We observed no correlation between serum levels and protein or mRNA expression in corresponding tumors (r < 0.1, p = n.s.). sALCAM levels were not correlated with histological type, grading, tumor stage, or patient age, but elevated sALCAM levels were associated with shorter disease-free survival (HR = 1.97, 95% CI 1.01-3.2, p = 0.043). Our results indicate that sALCAM can be detected in the serum of patients with primary breast cancer. Elevated serum levels might indicate more aggressive tumor behavior as they might be an independent factor for a worse prognosis in breast cancer patie...Continue Reading
References
Sep 25, 2001·Blood·O OhnedaT Suda
Jul 13, 2002·European Journal of Cell Biology·Guido W M Swart
Dec 14, 2002·The Prostate·Glen KristiansenAndré Rosenthal
Aug 21, 2004·Breast Cancer Research : BCR·Judy A KingWen G Jiang
Oct 29, 2004·Journal of Clinical Pathology·W WeichertG Kristiansen
Jun 30, 2005·Cancer Metastasis Reviews·Guido W M SwartLeon C L T van Kempen
Jul 19, 2005·Oncology·Amit VermaRanju Ralhan
Feb 18, 2006·Journal of Clinical Pathology·M BurkhardtG Kristiansen
Nov 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B-W ParkK S Lee
Jan 4, 2008·Molecular Cancer Research : MCR·Ombretta RossoMarina Fabbi
Jan 4, 2008·Breast Cancer Research and Treatment·M IhnenK Milde-Langosch
Mar 27, 2009·International Journal of Cancer. Journal International Du Cancer·Vathany KulasingamEleftherios P Diamandis
May 13, 2010·Journal of Surgical Oncology·Xin HongJörg Kleeff
Jul 14, 2010·Breast Cancer Research and Treatment·Isabell WitzelVolkmar Müller
Aug 24, 2010·Clinical and Experimental Immunology·P NairE Montero
Aug 26, 2010·British Journal of Cancer·M IhnenV Müller
Oct 26, 2010·Breast Cancer Research and Treatment·Sibyll HeinKarin Milde-Langosch
Mar 3, 2011·PloS One·Francesca MiccichèItalia Bongarzone
Citations
May 11, 2012·Experimental & Molecular Medicine·Chun Hua Wei, Seong Eon Ryu
Jan 23, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kayhan ErturkBurak Sakar
Nov 22, 2012·International Journal of Cancer. Journal International Du Cancer·Grazia CarbottiMarina Fabbi
Mar 1, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Leila EskandariMohammad Rahmati-Yamchi
Oct 16, 2016·BMC Endocrine Disorders·Alba SulajRüdiger von Bauer
Jul 12, 2016·Expert Review of Molecular Diagnostics·Meng XiaoWantao Chen
Jan 25, 2018·Clinical and Experimental Immunology·Y S KimM H Sohn
Dec 10, 2014·The Journal of Cell Biology·Miklós Müller, Caitlin Sedwick
Nov 29, 2016·Oncotarget·Shanna A Arnold EgloffAndries Zijlstra
Nov 24, 2019·Scientific Reports·Siew-Kee LowYoshio Miki
Nov 7, 2019·Oncotarget·Andrew J SandersWen G Jiang
Apr 24, 2018·Oncotarget·Laura DevisEva Colas
May 15, 2013·Cancer Research·Elisa PennaDaniela Taverna
Mar 30, 2013·Cancer Research·Amanda G HansenAndries Zijlstra
Jan 5, 2014·Cancer Research·Amanda G HansenAndries Zijlstra
Jul 18, 2021·Cytokine & Growth Factor Reviews·Fátima FerragutMaría T Elola
May 3, 2014·Journal of Proteome Research·Chi-De ChenJau-Song Yu
Dec 23, 2014·Analytical Chemistry·Duy P TranBenjamin Thierry
May 8, 2020·Experimental and Molecular Pathology·Behrad DarvishiLeila Farahmand